RecruitingPhase 1 / Phase 2NCT05919264
Rare condition
Hepatocellular adenoma
8
studies recruiting now
as of 7 Sept 2026
52
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
14 May 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT06971848
Evaluation of Skin Tests in Biotherapy Allergies
RecruitingPhase 2NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
RecruitingPhase 2NCT06638931
Agnostic Therapy in Rare Solid Tumors
RecruitingPhase 1 / Phase 2NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 8 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Hepatocellular adenoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Hepatocellular adenoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).